💨 Abstract

President Donald Trump signed an executive order directing drugmakers to lower medicine prices to match those in other countries. The order sets price targets and potential tariffs if expectations are not met, but analysts and legal experts doubt its feasibility, as similar efforts have been blocked by courts. Stocks of drugmakers initially fell but later rebounded. The order faces likely legal challenges and includes measures like importing medicines and targeting anti-competitive practices.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖